SCHEMBL1711950

SCHEMBL1711950

COc1cccc(C(=O)NC2CCN(C(=O)OC(C)(C)C)CC2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.69
TSHR P16473 1/20 0.69
LMNA P02545 2/20 0.60
MAPT P10636 1/20 0.60
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
USP30 Q70CQ3 2/20 0.57
MCHR1 Q99705 3/20 0.57
CCR3 P51677 1/20 0.54
KDM5A P29375 1/20 0.53
GRM5 P41594 1/20 0.53
USP2 O75604 1/20 0.52
POLB P06746 1/20 0.52
DRD4 P21917 1/20 0.52
KDM4E B2RXH2 1/20 0.51
PKM P14618 1/20 0.51
STS P08842 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12853559 0.88 USP30 (0.58) ALDH1A1TSHRMAPTMEN1KMT2A
SCHEMBL3124262 0.87 USP30 (0.62) ALDH1A1TSHRLMNAMAPTMEN1
SCHEMBL2957238 0.87 USP30 (0.54) ALDH1A1TSHRLMNAMAPTHTT
SCHEMBL28457523 0.86 ALDH1A1 (0.70) ALDH1A1LMNAMAPTSMN1; SMN2MEN1
SCHEMBL27633457 0.85 KMT2A (0.61) ALDH1A1MEN1KMT2AUSP30CCR3
SCHEMBL18050965 0.85 USP30 (0.58) ALDH1A1TSHRMAPTMEN1KMT2A
SCHEMBL2962791 0.85 ALDH1A1 (0.57) ALDH1A1TSHRLMNAMAPTNPSR1
SCHEMBL4574282 0.85 USP30 (0.60) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL13199301 0.85 KDM4E (0.68) LMNANPSR1MEN1KMT2AUSP30
SCHEMBL14655033 0.84 MEN1 (0.63) ALDH1A1MEN1KMT2APOLBSTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344471-B1 7-PIPERIDINOALKYL-3,4-DIHYDROQUINOLONE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2013-07-24 EP disclosed
US-8461182-B2 7-piperidinoalkyl-3, 4-Dihydroquinolone derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-06-11 US disclosed
US-20110178304-A1 7-PIPERIDINOALKYL-3, 4-DIHYDROQUINOLONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-07-21 US disclosed
EP-2344471-A1 7-PIPERIDINOALKYL-3,4-DIHYDROQUINOLONE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2011-07-20 EP disclosed
WO-2010038901-A1 7-PIPERIDINOALKYL-3,4-DIHYDROQUINOLONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-04-08 WO disclosed
US-20100081825-A1 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2010-04-01 US disclosed
EP-2098509-A1 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE Taisho Pharmaceutical Co. Ltd. (JP) 2009-09-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081825-A1 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE MCHR1, MCHR2, MC5R ALDH1A1 2065/4885TSHR 35/4885LMNA 2398/4885
US-20110178304-A1 7-PIPERIDINOALKYL-3, 4-DIHYDROQUINOLONE DERIVATIVE MCHR1, MCHR2, GPR119 ALDH1A1 1137/4885TSHR 126/4885LMNA 3909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.